Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |